Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature

Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature

Membranous nephropathy (MN), focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) are autoimmune kidney diseases and the most common causes of nephrotic syndrome. Anti-CD20 monoclonal antibodies are now recommended as first-line therapy for MN. Anti-CD20 monoclonal antibodies a...

Full description

Saved in:
Bibliographic Details
Main Authors: Pierre-Alexis Gauci, Marion Cremoni, Jérôme Delotte, Flavia Vocila, Vincent L. M. Esnault, Barbara Seitz-Polski, Maxime Teisseyre
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Renal Failure
Subjects:
Pregnancy
nephrotic syndrome
auto-immunity
rituximab
obinutuzumab
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2025.2481201
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2025.2481201

Similar Items